Header

Hookworm

Human Hookworm Vaccine Initiative featured in Case Studies for Global Health

Sabin Vaccine’s Human Hookworm Vaccine Initiative (HHVI) is one of 32 projects chosen for inclusion in Case Studies for Global Health released on November 20, 2009 by the Alliance for Case Studies for Global Health. The Alliance is a collaboration of The Bill & Melinda Gates Foundation, World Health Organization's Special Programme for Research and Training in Tropical Diseases (TDR), Global Health Progress (GHP), International AIDS Vaccine Initiative (IAVI) and Association of University Technology Managers (AUTM).

This widely respected publication features case studies addressing a global health concern, i.e. related to diseases that have a disproportionate impact on developing countries, and is intended to educate organizations or individuals who are currently involved or are interested in helping to fulfill global health objectives.

A Constitutional Amendment for Deworming
Sabin resourcePoint of View

In February 2009, The Washington Post reported that three South American countries, Bolivia, Ecuador, and Venezuela, have either launched or completed ambitious efforts to rewrite their constitutions in order to expand the social and economic rights guaranteed to its citizens [2]. The fact that millions of indigenous children and women in Latin America suffer from intestinal helminth infections is especially tragic because we can do something about these conditions through interventions that are astonishingly low cost [4].

State of the World's Vaccines and Immunizations

At the Sabin Vaccine Institute, we’re firm believers in the powerful role that vaccines and immunizations play in reducing needless suffering from infectious and neglected tropical diseases. Our convictions were confirmed in the World Health Organization (WHO), UNICEF, and World Bank’s “State of the World’s Vaccines and Immunizations” report released last month which affirmed the link between immunization and reducing poverty and mortality; improving general welfare and future productivity; preventing debilitating illness and disability; and achieving several Millennium Development Goals (MDGs), in particular, reducing deaths of children under the age of five.

Sabin Vaccine Institute Welcomes National Youth Leadership Forum on Medicine

On Thursday, July 9th, Sabin Vaccine Institute will host a group of students from the National Youth Leadership Forum on Medicine. The students will experience presentations from Sabin's Vaccine Development Program, the Global Network, and the Vaccine Advocacy & Education Program. They will also tour the laboratories at George Washington University where the Vaccine Development Program is currently developing vaccines for hookworm and schistosomiasis, diseases that continue to afflict hundreds of thousands of people living in developing countries around the world.

Prof. Peter Hotez is Awarded an Honorary Fellowship of the Royal Society of Hygiene and Tropical Medicine

Washington, DC - Prof. Peter Hotez, MD, PhD was named today an Honorary Fellow of the Royal Society of Hygiene and Tropical Medicine (RSHTM). The award has been a tradition of RSHTM for more than 100 years and is presented to individuals who have made outstanding contributions towards the objectives of the Society. RSHTM's mission is to promote and advance the study, control, prevention and treatment of tropical diseases, to facilitate discussion, exchange of information and promotion of the health of those affected by tropical diseases.

Archived Event
Never a Greater Need: Social Investment and Philanthropy in Times of Crisis

Kari Stoever of Sabin Vaccine Institute/Global Network for Neglected Tropical Diseases will be a featured speaker at a breakfast sponsored by the Inter-American Development Bank (IDB), Group of Institutes, Foundations and Enterprises (GIFE), Schwab Foundation, and Synergos Institute in conjunction with the World Economic Forum on Latin American being held from April 14th to April 16th, 2009.

Just 50 Cents: A Best Buy in Public Health
Sabin resourceVideo

Neglected tropical diseases threaten millions throughout the developing world each year, but for just 50 cents, you can help fund a rapid-impact package of medications to treat the seven most common NTDs. Watch the video to learn more and find out how you change the world – through just 50 cents. Donate now!

Neglected Disease Research & Development: How Much are We Really Spending?
External resourceResearch

Moran M, Guzman J, Ropars A:, McDonald A, Sturm T, Jameson N, Wu L, Ryan S, Umune B (2009) Neglected Disease Research & Development: How Much Are We Really Spending? The George Institute for International Health, February 2009.